Skip to main content

Ophthalmic Drugs Market Growth & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...
Post a Comment
Read more

Which are the biggest markets (regions) for Insulin Pen?

    The global Insulin Pen market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Insulin Pen from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Insulin Pen market. Download Free Sample  -  https://www.radiantinsights.com/research/2013-2028-report-on-global-insulin-pen-market/request-sample Leading players of Insulin Pen including: Novo Nordisk Sanofi-Aventis Eli Lilly OWEN Mumford WOCKHARDT Dongbao(YPSOMED) Gan & Lee Market split by Type, can be divided into: Reusable Insulin Pen Disposable Insulin Pen Market split by Application, can be divided into: Hospitals Clinics The Chemist's Shops Market sp...
Post a Comment
Read more

Asthma Market Current Scenario And Industry Forecasts Till, 2014 - 2025

Asthma Market size such as the patent expiry of drugs, high expenditure on treatment, and growth in the use of generic drugs. The global Asthma Market size spans type, device type, drug type, route of administration, and geography. Based on type, the global Asthma Market size constitutes allergic asthma and non-allergic asthma. Allergic asthma is caused due to exposure to allergens like pollens from weeds, trees, etc., dust, and so on. On the other hand, non-allergic asthma is caused due to exercise, stress, cold, flu, etc. Download Free Sample  -  https://www.millioninsights.com/industry-reports/asthma-market/request-sample Based on device type, the global Asthma Market size constitutes inhalers and nebulizers. The “inhalers” segment is further sub-categorized as dry powder, soft mist inhalers (SMIs), metered-dose inhalers (MDIs). Nebulizers are devices that carry the drug in a fluid form that is dispensed by compressed air. The “nebulizers” segment is further sub-categorized...
Post a Comment
Read more